HomeNEUP • NASDAQ
add
Neuphoria Therapeutics Inc
Previous close
$5.12
Day range
$5.11 - $5.25
Year range
$2.91 - $12.55
Market cap
9.14M USD
Avg Volume
40.40K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | 662.72K | — |
Operating expense | 2.32M | -4.14% |
Net income | -1.94M | 57.33% |
Net profit margin | -293.24 | — |
Earnings per share | — | — |
EBITDA | -3.23M | 24.72% |
Effective tax rate | -0.60% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 4.34M | -57.13% |
Total assets | 18.17M | -31.40% |
Total liabilities | 4.42M | -33.96% |
Total equity | 13.75M | — |
Shares outstanding | 1.76M | — |
Price to book | 0.61 | — |
Return on assets | -41.34% | — |
Return on capital | -54.43% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | -1.94M | 57.33% |
Cash from operations | -3.36M | 14.88% |
Cash from investing | — | — |
Cash from financing | -111.56K | -101.98% |
Net change in cash | -3.75M | -285.05% |
Free cash flow | -2.07M | — |
About
Founded
1996
Headquarters
Website
Employees
16
